These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Analysis of oxidized and nitrated proteins in plasma and tissues as biomarkers for exposure to reactive oxygen and nitrogen species. Ohshima H; Pignatelli B; Li CQ; Baflast S; Gilibert I; Boffetta P IARC Sci Publ; 2002; 156():393-4. PubMed ID: 12484216 [No Abstract] [Full Text] [Related]
49. [Circulating blood in patients with cancer of the stomach]. Marczyńska A; Szczygiel K; Adamczyk B; Kubas Z; Oszacki J Pol Przegl Chir; 1967 Feb; 39(2):155-62. PubMed ID: 6040907 [No Abstract] [Full Text] [Related]
51. [Morphology of erythrocytes and erythropoiesis in gastric cancer and precancer]. BRAMBERGA VM Vopr Klin Lecheniia Zlokachestvennykh Novoobraz; 1956; 4():105-27. PubMed ID: 13468306 [No Abstract] [Full Text] [Related]
52. CA 125 as an indicator of pleural metastases in breast cancer patients. Krämer S; Raff U; Jäger W; Lang N Anticancer Res; 1996; 16(5B):3165-8. PubMed ID: 8920785 [TBL] [Abstract][Full Text] [Related]
53. Use of plasma in serum tumour marker assays: cancer-associated serum antigen and mammary serum antigen. Devine PL; Quin RJ Eur J Clin Chem Clin Biochem; 1994 Aug; 32(8):629-30. PubMed ID: 7819434 [No Abstract] [Full Text] [Related]
54. [Studies on the acute normovolemic hemodilution. Part II. Preoperative intentional hemodilution in the patients with elective surgeries (author's transl)]. Asoh T Fukuoka Igaku Zasshi; 1980 Feb; 71(2):94-106. PubMed ID: 7380381 [No Abstract] [Full Text] [Related]
55. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer. Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811 [TBL] [Abstract][Full Text] [Related]
56. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies. Karapanagiotou EM; Pelekanou E; Charpidou A; Tsaganos T; Anagnostou V; Plachouras D; Giamarellos-Bourboulis EJ; Syrigos KN Anticancer Res; 2008; 28(2B):1411-5. PubMed ID: 18505088 [TBL] [Abstract][Full Text] [Related]
57. [Comparative analysis of lung, stomach and breast cancers on the basis of findings of quantitative DNA and oxidoreductase histochemistry]. Serov VV; Zolotarevskiĭ VB; Kogan EA; Krysteva-Sedmakova LTs; Kudriavtsev IuV; Sklianskaia OA Vestn Akad Med Nauk SSSR; 1981; (12):39-49. PubMed ID: 7331490 [No Abstract] [Full Text] [Related]
58. Suramin and serum insulin-like growth factor levels in metastatic cancer patients. Miglietta L; Barreca A; Repetto L; Costantini M; Rosso R; Boccardo F Anticancer Res; 1993; 13(6B):2473-6. PubMed ID: 8135485 [TBL] [Abstract][Full Text] [Related]
59. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A; Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304 [TBL] [Abstract][Full Text] [Related]
60. [Clinical features and diagnosis of pulmonary lymphangitic carcinomatosis]. Zhang K; Huang Y Ai Zheng; 2006 Sep; 25(9):1127-30. PubMed ID: 16965655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]